AKBA · Akebia Therapeutics, Inc. · Executive Compensation
$0.42
+0.01 (+3.28%)
At close · Nov 19
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Market Cap
$117.26M
Shares
277.66M
Volume · Nov 19
2.75M
Avg daily vol (3M)
8.17M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| John P. Butler | President and Chief Executive Officer — | $5,652,339 |
| Steven Burke | M.D., Senior Vice President, Chief Research & Development and Medical Officer — | $1,859,815 |
| Erik Ostrowski | Senior Vice President, Chief Financial Officer, Chief Business Officer and Treasurer | $1,792,361 |
| Nicholas Grund | Senior Vice President, Chief Commercial Officer | $1,728,405 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| John P. Butler | President and Chief Executive Officer | $4,260,114 |
| Nicholas Grund | Senior Vice President, Chief Commercial Officer | $1,854,631 |
| Steven Burke | M.D., Senior Vice President, Research & Development and Chief Medical Officer | $1,811,027 |
| Erik Ostrowski | Senior Vice President, Chief Financial Officer, Chief Business Officer and Treasurer | $1,215,122 |
| Michel Dahan | Former Senior Vice President, Chief Operating Officer | $1,212,463 |
| Ellen Snow | Former Senior Vice President, Chief Financial Officer and Treasurer | $1,048,621 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| John P. Butler | President and Chief Executive Officer | $2,775,123 |
| Ellen Snow | Former Senior Vice President, Chief Financial Officer and Treasurer | $1,715,814 |
| Michel Dahan | Former Senior Vice President, Chief Operating Officer | $1,245,374 |
| Steven Burke | M.D., Senior Vice President, Research & Development and Chief Medical Officer | $1,213,048 |
| Nicole R. Hadas | Senior Vice President, Chief Legal Officer | $1,046,304 |
| David A. Spellman | Former Senior Vice President, Chief Financial Officer and Treasurer | $942,627 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| John P. Butler | President and Chief Executive Officer | $3,072,538 |
| David A. Spellman | Former Senior Vice President, Chief Financial Officer and Treasurer | $1,585,841 |
| Steven Burke | M.D., Senior Vice President, Research & Development and Chief Medical Officer | $1,378,557 |
| Michel Dahan | Former Senior Vice President, Chief Operating Officer | $1,287,386 |
| Nicole R. Hadas | Senior Vice President, Chief Legal Officer | $1,240,038 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| John P. Butler | President and Chief Executive Officer | $3,133,316 |
| David A. Spellman | Former Senior Vice President, Chief Financial Officer and Treasurer | $1,721,477 |
| Steven Burke | M.D., Senior Vice President, Chief Medical Officer | $1,346,572 |
| Michel Dahan | Senior Vice President, Chief Operating Officer | $1,267,970 |
| Nicole R. Hadas | Senior Vice President, Chief Legal Officer | $1,230,453 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Nicholas Grund | Senior Vice President and Chief Commercial Officer | Resigned | 2026-10-14 |
| Philip J. Vickers, Ph.D. | Class I director | Appointed | 2026-04-01 |
| Myles Wolf | Class II director |
Already on the board
Since at least 2020: re-election or new board role
|
2025-06-13 |
| John P. Butler | Class II director | Appointed | 2025-06-13 |
| Erik Ostrowski | Senior Vice President, Chief Financial Officer, Chief Business Officer, Treasurer and principal financial officer | Appointed | 2024-06-24 |
| Ellen Snow | Senior Vice President, Chief Financial Officer and Treasurer | Resigned | 2024-03-15 |
| Richard C. Malabre | Chief Accounting Officer and principal accounting officer | Appointed | 2024-01-08 |
| Nicole R. Hadas | Senior Vice President, Chief Legal Officer and Corporate Secretary | Terminated | 2023-08-01 |
| Michel Dahan | Chief Operating Officer | Terminated | 2023-08-01 |
| Ellen Snow | Senior Vice President, Chief Financial Officer, Treasurer, principal financial officer and principal accounting officer | Appointed | 2023-06-13 |
| David A. Spellman | Senior Vice President, Chief Financial Officer, Treasurer, principal financial officer and principal accounting officer | Resigned | 2023-06-13 |
| LeAnne M. Zumwalt | Class III director |
Already on the board
Since at least 2021: re-election or new board role
|
2023-06-08 |
| Michael Rogers | Class III director |
Already on the board
Since at least 2018: re-election or new board role
|
2023-06-08 |
| Adrian Adams | Class III director |
Already on the board
Since at least 2018: re-election or new board role
|
2023-06-08 |
| Violetta Cotreau | Chief Accounting Officer | Resigned | 2022-12-15 |
| Ron Frieson | Class I director | Appointed | 2021-11-01 |
Leadership
- John Butler CEO, CFO, Board Member
- John P. Butler CEO, Board Member
- Ellen Snow CFO
- Erik Ostrowski CFO
- Michel Dahan COO
- David A. Spellman Chief Accounting Officer
- Richard C. Malabre Chief Accounting Officer
- Adrian Adams Board Member
- LeAnne M. Zumwalt Board Member
- Michael Rogers Board Member
- Myles Wolf, M.D., M.M.Sc. Board Member
- Myles Wolf, M.D., M.S.Sc. Board Member
- Philip J. Vickers, Ph.D. Board Member
- Ron Frieson Board Member
Key facts
CIK
1517022
CUSIP
00972D105
13F (30d)
157 filings
140 filers
Visit website
Investor relations